Differences in Psychometric Properties of Clinician- and Patient-Reported Outcome Measures for Atopic Dermatitis by Race and Skin Tone: A Systematic Review
- Authors:
- Kaundinya, T., Rakita, U., Guraya, A., Abboud, D. M., Croce, E., Thyssen, J. P., Alexis, A., and Silverberg, J. I.
- Abstract:
- The psychometric validity and reliability of widely used atopic dermatitis (AD) outcome measures across different races and ethnicities are unclear. We describe the rates of reporting race, ethnicity, and skin tone in studies testing the psychometric properties of AD outcome measures and compare the psychometric analyses across race, ethnicity, and skin tone. We systematically reviewed MEDLINE and EMBASE for studies reporting psychometric properties of clinician-reported or patient-reported outcome measures in AD (International Prospective Register of Systematic Reviews: CRD42021239614). Overall, 16,100 nonduplicate articles were screened; 165 met inclusion criteria. Race and/or ethnicity were reported in 55 (33.3%) studies; of those, race was assessed by self-report in 10 studies (6.1%) or was unspecified in 45 (27.3%). A total of 16 studies (9.7%) evaluated psychometric property differences by race, and only five (4.4%) of those did not recognize it as a limitation. Properties assessed across race, ethnicity, or skin tone were differential item functioning, convergent validity feasibility, inter-rater reliability, intrarater reliability, test‒retest reliability, and known-groups validity. Multiple instruments demonstrated performance differences across ethnoracial groups. This review highlights the paucity of race/ethnicity consideration for psychometric property testing in AD outcome measurement instruments. More AD outcomes instruments should be validated in diverse populations.
- DOI:
- 10.1016/j.jid.2021.06.033
- URL:
- https://www.sciencedirect.com/science/article/pii/S0022202X21016328?via%3Dihub
- Journal:
- J Invest Dermatol
- issn:
- 0022-202X (Print)
- Publication year:
- 2022
- pages:
- 364-381
- Biological and physiological variables:
- Biological and physiological variables
- Symptom status:
- Physical state
- General health perceptions / HRQoL:
- Health-related quality of life
- Age:
- Adults (18-65)
Children (0-18)
Seniors (65+) - Disease:
- Diseases of and symptoms related to the skin and subcutaneous tissue
- PRO / non-PRO:
- Non-patient Reported Outcome
Patient Reported Outcome - Type of measurement instrument:
- 1 - Questionnaires
6 - Clinical rating scales - Instrument:
- 5D Itch Scale - 5 Dimensions Itch Scale
DLQI - Dermatology Life Quality Index
EASI - Eczema Area and Severity Index (versions: SA-EASI - Self-Administrered EASI; SA-EASI adapted; Clinician rated EASI)
ESS - Eczema Severity Score
Greyscale
HADS - Hospital Anxiety and Depression Scale
IGA - Investigators Global Assessment Scale (versions: 5-point IGA; 6-point IGA; 7-point IGA)
ItchyQOL - Itchy Quality of Life
NRS - Numeric Rating Scale (versions: NRS-6; NRS-11; NRS-21; NRS-101; NPRS - NRS Pain)
PHQ - Patient Health Questionnaire (versions: PHQ-2; PHQ-4; PHQ-8; PHQ-9; PHQ-9 short; aPHQ-9; PHQ-A; PHQ-22; PHQ-8; PHQ-15)
PIQ - Patient-reported Outcome Measures Information System Itch Questionnaire (versions: PIQ-MS - PIQ-Mood and Sleep; PIQ-MS-SF)
POEM - Patient-Oriented Eczema Measure (versions: POEM in Children; POEM in Adolscents)
PROMIS Sleep (versions: Sleep Disturbance-SF; Sleep Related Impairment)
SASSAD Index - Six-Area, Six-Sign Atopic Dermatitis Index
SCORAD - SCOring Atopic Dermatitis index (versions: SCORAD-Subjective; oSCORAD - objectieve SCORAD; SCORAD-physician; PO-SCORAD - Patient Oriented SCORAD)
Self-reported Global AD Severity (AD - Atopic Dermatitis)
SF-12 - 12-item Short Form Health Survey [alias: RAND-12] (versions: SF-12v2; VR-12 - Veterans SF-12; SF-12 MCS; SF-12 PCS)
SGAxBSA - Sign Global Assessment and Body Surface Area
TISS - Three Item Severity Score